CEO Update – December 2018

CEO Update – December 2018 In 2018, we were successful in our plan to expand our clinical program in Colorado, Washington, and Minnesota.  Our hope in 2019 is to continue to expand into additional markets including Texas, Utah, Illinois, Florida and Nevada. Additional projects we are hoping to complete in 2019 are a collaborative research…

New York Times Highlights Ketamine in the Treatment of Suicide

New York Times Highlights Ketamine in the Treatment of Suicide The New York Times recently ran an op-ed piece by Moises Velasquez-Manoff titled, “Can We Stop Suicides”, highlighting Ketamine as a breakthrough treatment option for treating suicidality and depression. This publication covers the story of a woman named Louise who struggled with depression and suicidality…